The Sabin PDP is focused on the development of sustainable and cost-effective vaccines for preventing widespread neglected tropical diseases (NTDs), including hookworm, schistosomiasis, Chagas disease and leishmaniasis.

The Sabin PDP is the only product development partnership in the world targeting human hookworm infection which would alleviate the suffering of more than half a billion infected people. In 2008, Sabin PDP launched an initiative to develop a vaccine against schistosomiasis, which infects over 200 million people around the world and is the deadliest disease of the seven most prevalent NTDs, killing an estimated 280,000 people annually.

The Sabin PDP recently initiated development for a new therapeutic vaccine for Chagas disease that will be undertaken with partners in Mexico, where between one and six million people are infected with this leading cause of poverty in Latin America.